Emergent Biosolutions Inc. buy Rodman & Renshaw
Start price
13.09.24
/
50%
€7.16
Target price
13.09.25
€14.43
Performance (%)
-4.47%
End price
14.09.25
€6.84
Summary
This prediction ended on 14.09.25 with a price of €6.84. With a performance of -4.47%, the BUY prediction by Rodman___Renshaw finished with a loss. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Emergent Biosolutions Inc. | -4.993% | -4.993% | 20.855% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Rodman___Renshaw for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Rodman & Renshaw. They now have a $16.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
In the thread Trading Emergent Biosolutions Inc.
Die von Rodman___Renshaw gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Rodman___Renshaw for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€9.52
22.08.24
22.08.24
€14.36
22.08.25
22.08.25
-18.30%
23.08.25
23.08.25
